Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00609466Phase 3Completed
Phase 3, randomised, double-blind trial of tapentadol in postoperative pain (3 arms), sponsored by Grünenthal GmbH. Primary endpoint: Sum of Pain Intensity Differences Relative to the Baseline Pain Intensity over 48 Hours. Started Sep 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00609466.